Trademark: 97149196
Status Date
Tuesday, January 16, 2024
Filing Date
Tuesday, November 30, 2021
Published for Opposition
Tuesday, May 30, 2023
42 Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Jan 18, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 16, 2024
Sou Extension 1 Granted
Jan 16, 2024
Sou Extension 1 Filed
Jan 16, 2024
Sou Teas Extension Received
Jul 25, 2023
Noa E-Mailed - Sou Required From Applicant
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Published For Opposition
May 10, 2023
Notification Of Notice Of Publication E-Mailed
Apr 27, 2023
Approved For Pub - Principal Register
Apr 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 17, 2023
Teas Change Of Correspondence Received
Apr 17, 2023
Teas Change Of Owner Address Received
Mar 21, 2023
Teas/Email Correspondence Entered
Mar 20, 2023
Correspondence Received In Law Office
Mar 20, 2023
Teas Response To Office Action Received
Sep 21, 2022
Notification Of Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action Written
Sep 7, 2022
Assigned To Examiner
Dec 4, 2021
New Application Office Supplied Data Entered
Dec 3, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
